PRME Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 24.29%

Insider Buying (Last 12 Months): $20,000,000.00

Insider Selling (Last 12 Months): $3,683,727.59

Prime Medicine Insider Trading History Chart

Prime Medicine Share Price & Price History

^$5.55

▼ -0.06 (-1.07%)

As of 05/3/2024 03:16 PM ET

Days: 30 | 90 | 365

Forget Bitcoin: This $8 Stock Is the Next Big Thing

From Behind the Markets | Ad

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>

Prime Medicine Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/15/2024	Robert Nelsen	Director	Buy	3,200,000	$6.25	$20,000,000.00	3,200,000
6/20/2023	2019 Gp L.L.C. Gv	Major Shareholder	Sell	37,405	$15.06	$563,319.30
6/16/2023	2019 Gp L.L.C. Gv	Major Shareholder	Sell	6,532	$15.02	$98,110.64
6/14/2023	2019 Gp L.L.C. Gv	Major Shareholder	Sell	28,960	$14.87	$430,635.20
6/12/2023	2019 Gp L.L.C. Gv	Major Shareholder	Sell	16,031	$14.98	$240,144.38
6/9/2023	2019 Gp L.L.C. Gv	Major Shareholder	Sell	15,672	$14.48	$226,930.56
6/5/2023	2019 Gp L.L.C. Gv	Major Shareholder	Sell	22,434	$16.70	$374,647.80
5/31/2023	2019 Gp L.L.C. Gv	Major Shareholder	Sell	16,633	$13.65	$227,040.45
5/26/2023	2019 Gp L.L.C. Gv	Major Shareholder	Sell	12,602	$13.70	$172,647.40
5/24/2023	2019 Gp L.L.C. Gv	Major Shareholder	Sell	7,900	$13.66	$107,914.00
5/22/2023	2019 Gp L.L.C. Gv	Major Shareholder	Sell	87,922	$14.13	$1,242,337.86

Biden to Launch “FedNOW” [Move Your Money Now]

From Priority Gold | Ad

Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...

Get your free information kit NOW, before it's too late.

SEC Filings (Institutional Ownership Changes) for Prime Medicine (NYSE:PRME)

70.37% of Prime Medicine stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Prime Medicine Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/3/2024	Nikko Asset Management Americas Inc.	3,364,663	$23.52M	0.2%	-4.4%	2.803%
4/29/2024	China Universal Asset Management Co. Ltd.	22,378	$0.16M	0.0%	+98.8%	0.019%
4/19/2024	Sumitomo Mitsui Trust Holdings Inc.	3,364,663	$23.55M	0.0%	-4.4%	2.805%
4/15/2024	TrueMark Investments LLC	85,183	$0.60M	0.5%	+13.5%	0.071%
4/10/2024	Green Alpha Advisors LLC	33,738	$0.24M	0.2%	+14.2%	0.028%
2/21/2024	Chelsea Counsel Co.	5,000	$44K	0.0%	+733.3%	0.005%
2/14/2024	Vestal Point Capital LP	20,306	$0.18M	0.0%	N/A	0.021%
2/13/2024	Bollard Group LLC	361,136	$3.20M	0.1%	N/A	0.371%
2/9/2024	Trexquant Investment LP	26,983	$0.24M	0.0%	N/A	0.028%
2/8/2024	Nikko Asset Management Americas Inc.	3,519,029	$31.18M	0.3%	-3.2%	3.616%
2/6/2024	Vestmark Advisory Solutions Inc.	144,288	$1.28M	0.1%	N/A	0.148%
2/6/2024	Levin Capital Strategies L.P.	20,000	$0.18M	0.0%	N/A	0.021%
2/1/2024	New York State Common Retirement Fund	8,440	$75K	0.0%	-48.3%	0.009%
2/1/2024	Greenwich Wealth Management LLC	513,001	$4.55M	0.4%	+16.9%	0.527%
1/30/2024	Strs Ohio	17,100	$0.15M	0.0%	N/A	0.018%
1/30/2024	Sumitomo Mitsui Trust Holdings Inc.	3,519,029	$31.18M	0.0%	-3.2%	3.616%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	21,301	$0.19M	0.0%	-7.5%	0.022%
1/24/2024	China Universal Asset Management Co. Ltd.	11,258	$100K	0.0%	N/A	0.012%
1/17/2024	ARK Investment Management LLC	3,138,270	$27.81M	0.2%	+19.7%	3.225%
1/12/2024	SG Americas Securities LLC	10,128	$90K	0.0%	N/A	0.010%
1/11/2024	TrueMark Investments LLC	75,030	$0.67M	0.7%	N/A	0.077%
1/5/2024	Green Alpha Advisors LLC	29,538	$0.26M	0.2%	-21.9%	0.030%
12/18/2023	Vanguard Group Inc.	3,951,793	$37.70M	0.0%	+18.5%	4.060%
12/6/2023	Citigroup Inc.	56,193	$0.54M	0.0%	+296.8%	0.058%
11/14/2023	Profund Advisors LLC	21,995	$0.21M	0.0%	N/A	0.023%
11/13/2023	FMR LLC	3,922,416	$37.42M	0.0%	-2.9%	4.030%
11/13/2023	Rafferty Asset Management LLC	128,876	$1.23M	0.0%	N/A	0.132%
11/9/2023	Citigroup Inc.	56,193	$0.54M	0.0%	+296.8%	0.058%
11/8/2023	Oppenheimer & Co. Inc.	21,537	$0.21M	0.0%	+40.0%	0.022%
11/7/2023	Barclays PLC	65,140	$0.62M	0.0%	+726.8%	0.067%
11/7/2023	Greenwich Wealth Management LLC	439,021	$4.19M	0.4%	+111.1%	0.451%
10/30/2023	Sumitomo Mitsui Trust Holdings Inc.	3,634,848	$34.68M	0.0%	+18.6%	3.736%
10/27/2023	Allspring Global Investments Holdings LLC	3,067	$29K	0.0%	-73.2%	0.003%
10/27/2023	TD Asset Management Inc	104,542	$1M	0.0%	+55.9%	0.107%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	23,016	$0.22M	0.0%	+22.0%	0.024%
10/24/2023	Bank of New York Mellon Corp	115,389	$1.10M	0.0%	+11.8%	0.119%
10/18/2023	ARK Investment Management LLC	2,622,429	$25.02M	0.2%	+7.1%	2.695%
10/10/2023	Green Alpha Advisors LLC	37,815	$0.36M	0.3%	+205.3%	0.039%
9/21/2023	Barclays PLC	7,879	$0.12M	0.0%	+47.7%	0.008%
8/14/2023	Casdin Capital LLC	367,175	$5.38M	0.5%	-50.0%	0.377%
8/11/2023	Penserra Capital Management LLC	8,107	$0.12M	0.0%	+15.8%	0.008%
8/10/2023	Metropolitan Life Insurance Co NY	2,203	$32K	0.0%	+206.8%	0.002%
8/9/2023	TD Asset Management Inc	67,071	$0.98M	0.0%	+180.4%	0.069%
8/7/2023	Principal Financial Group Inc.	18,029	$0.26M	0.0%	N/A	0.019%
8/7/2023	Brown Brothers Harriman & Co.	10,065	$0.15M	0.0%	N/A	0.010%
8/4/2023	American International Group Inc.	19,040	$0.28M	0.0%	+274.3%	0.020%
8/4/2023	Alphabet Inc.	11,862,498	$173.79M	9.3%	-10.7%	12.200%
7/31/2023	Levin Capital Strategies L.P.	20,000	$0.29M	0.0%	N/A	0.021%
7/31/2023	Greenwich Wealth Management LLC	208,000	$3.05M	0.3%	-40.4%	0.214%
7/31/2023	Sumitomo Mitsui Trust Holdings Inc.	3,063,751	$44.88M	0.0%	+207.1%	3.151%
7/24/2023	Allspring Global Investments Holdings LLC	11,441	$0.17M	0.0%	+894.0%	0.012%
7/18/2023	Allspring Global Investments Holdings LLC	11,441	$0.17M	0.0%	+894.0%	0.012%
7/10/2023	ARK Investment Management LLC	2,449,199	$35.88M	0.2%	+27.4%	2.519%
7/6/2023	Green Alpha Advisors LLC	12,386	$0.18M	0.1%	N/A	0.013%

Data available starting January 2016

Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address the spectrum of diseases by deploying gene editing technology. The company offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. It has a research collaboration with Cimeio Therapeutics to develop Prime Edited Shielded-Cell & Immunotherapy Pairs for genetic diseases, acute myeloid leukemia, and myelodysplastic syndrome. The company was incorporated in 2019 and is based in Cambridge, Massachusetts.

Today's Range

Now: $5.55

$5.45

$6.09

50 Day Range

MA: $6.61

$4.30

$9.39

52 Week Range

Now: $5.55

$4.11

$17.20

Volume

684,122 shs

Average Volume

701,170 shs

Market Capitalization

$666.17 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.07

Who are the company insiders with the largest holdings of Prime Medicine?: Prime Medicine's top insider shareholders include:
Robert Nelsen (Director)
2019 Gp LLC Gv (Major Shareholder)
Learn More about top insider investors at Prime Medicine.
Who are the major institutional investors of Prime Medicine?: Prime Medicine's top institutional shareholders include:
Nikko Asset Management Americas Inc. — 2.80%
Sumitomo Mitsui Trust Holdings Inc. — 2.81%
TrueMark Investments LLC — 0.07%
Green Alpha Advisors LLC — 0.03%
China Universal Asset Management Co. Ltd. — 0.02%
Learn More about top institutional investors of Prime Medicine stock.
Which major investors are selling Prime Medicine stock?: Within the previous quarter, PRME stock was sold by these institutional investors:
Sumitomo Mitsui Trust Holdings Inc.
Nikko Asset Management Americas Inc.
Which major investors are buying Prime Medicine stock?: Within the previous quarter, PRME stock was bought by institutional investors including:
China Universal Asset Management Co. Ltd.
TrueMark Investments LLC
Green Alpha Advisors LLC